What next for the lung cancer treatment?
AstraZeneca, in cooperation with the Moi Teaching and Referral Hospital (MTRH), has introduced a molecular testing platform to enhance lung cancer diagnostics to help lower cost of cancer treatment. The agreement, under AstraZeneca’s Cancer Care Africa (CCA) initiative, will strengthen the diagnostic capabilities in the public sector, providing Kenyan patients with access to technology to […]
Continue Reading